10+ New Client Wins including Forbes* Global Top 10 Life Sciences Companies.

Freyr adds 10+ new clients to emerge as a Global Regulatory Services Partner of Choice for 6 of the Forbes* Global Top 10 Fortune 500 Healthcare / Life Sciences, Mid-market $1+ Billion Bio Pharma, and Several Small-Medium, Fast Growing Life Sciences companies, CROs and Standards agencies.

Freyr is redefining the Regulatory supporting services industry by pioneering innovative regulatory solutions and services suite to help clients navigate the regulatory compliance landscape effectively, efficiently and quickly.

Keeping up its global momentum of new business acquisition, Freyr has expanded its new client base to include several Fortune 500 and small, medium pharma, life sciences and medical device companies.

With the addition of 10+ new global clients to its rapidly growing clientele, Freyr has emerged as the partner of choice for Global Top 10, mid-market and fast growing small-medium – Healthcare, Life Sciences, Biotech, Bio-Pharma companies, CROs and Standards agencies.

As part of its global business expansion strategy Freyr has initiated its global operations and footprint expansion plans. This development will form the operational backbone to serve Freyr’s strategic Delivery center, Regulatory CoEs and R&D Services workforce.

With a rapidly increasing headcount crossing 400+ regulatory experts across global locations, Freyr is setting into motion a major expanding project for its data & development center and several of its affiliate facilities in US, Middle East, South Africa and India.

*Source – Forbes